First Manhattan
TECH icon

First Manhattan’s Bio-Techne TECH Stock Holding History

First Manhattan’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-56
Closed -$4.64K – 1697
2022
Q4 		$4.64K Sell
56
-28
-33% -$2.22K ﹤0.01% 1418
2022
Q3 		$5K Hold
84
– – ﹤0.01% 1321
2022
Q2 		$7K Hold
84
– – ﹤0.01% 1290
2022
Q1 		$9K Hold
84
– – ﹤0.01% 1302
2021
Q4 		$10K Hold
84
– – ﹤0.01% 1288
2021
Q3 		$10K Hold
84
– – ﹤0.01% 1285
2021
Q2 		$9K Hold
84
– – ﹤0.01% 1304
2021
Q1 		$8K Buy
+84
New +$7.66K ﹤0.01% 1276

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

First Manhattan's TECH Position: Q1 2023 in Review

First Manhattan sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 56 shares — an estimated $4.64K sold.

First Manhattan first reported a position in TECH in Q1 2021 and held it in 8 quarters. The position peaked at $10K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • First Manhattan reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • First Manhattan sold 56 Bio-Techne shares in Q1 2023, an estimated $4.64K.
  • First Manhattan first reported a position in Bio-Techne in Q1 2021 and held it in 8 quarters.
  • First Manhattan's Bio-Techne position peaked at $10K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.